Literature DB >> 31619549

Completing the Translation.

Robert T McCormack1, Daniel F Hayes2,3.   

Abstract

Year:  2019        PMID： 31619549     DOI： 10.1634/theoncologist.2019-0650

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  14 in total

1.  Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.

Authors:  Danny R Welch
Journal:  Cancer Res       Date:  2016-01-03       Impact factor: 12.701

2.  Liquid biopsy: Potential and challenges.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Mol Oncol       Date:  2016-02-01       Impact factor: 6.603

Review 3.  Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.

Authors:  Christian Rolfo; Philip C Mack; Giorgio V Scagliotti; Paul Baas; Fabrice Barlesi; Trever G Bivona; Roy S Herbst; Tony S Mok; Nir Peled; Robert Pirker; Luis E Raez; Martin Reck; Jonathan W Riess; Lecia V Sequist; Frances A Shepherd; Lynette M Sholl; Daniel S W Tan; Heather A Wakelee; Ignacio I Wistuba; Murry W Wynes; David P Carbone; Fred R Hirsch; David R Gandara
Journal:  J Thorac Oncol       Date:  2018-06-06       Impact factor: 15.609

Review 4.  Liquid biopsy: monitoring cancer-genetics in the blood.

Authors:  Emily Crowley; Federica Di Nicolantonio; Fotios Loupakis; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2013-07-09       Impact factor: 66.675

Review 5.  Circulating Tumor DNA as a Liquid Biopsy: Current Clinical Applications and Future Directions.

Authors:  Kimberly M Komatsubara; Adrian G Sacher
Journal:  Oncology (Williston Park)       Date:  2017-08-15       Impact factor: 2.990

6.  Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors.

Authors:  Ryan N Ptashkin; Diana L Mandelker; Catherine C Coombs; Kelly Bolton; Zarina Yelskaya; David M Hyman; David B Solit; José Baselga; Maria E Arcila; Marc Ladanyi; Liying Zhang; Ross L Levine; Michael F Berger; Ahmet Zehir
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

Review 7.  Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Authors:  Jason D Merker; Geoffrey R Oxnard; Carolyn Compton; Maximilian Diehn; Patricia Hurley; Alexander J Lazar; Neal Lindeman; Christina M Lockwood; Alex J Rai; Richard L Schilsky; Apostolia M Tsimberidou; Patricia Vasalos; Brooke L Billman; Thomas K Oliver; Suanna S Bruinooge; Daniel F Hayes; Nicholas C Turner
Journal:  J Clin Oncol       Date:  2018-03-05       Impact factor: 44.544

8.  Tumour heterogeneity in the clinic.

Authors:  Philippe L Bedard; Aaron R Hansen; Mark J Ratain; Lillian L Siu
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

9.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Authors:  Steven M Teutsch; Linda A Bradley; Glenn E Palomaki; James E Haddow; Margaret Piper; Ned Calonge; W David Dotson; Michael P Douglas; Alfred O Berg
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

10.  Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.

Authors:  Leticia De Mattos-Arruda; Regina Mayor; Charlotte K Y Ng; Britta Weigelt; Francisco Martínez-Ricarte; Davis Torrejon; Mafalda Oliveira; Alexandra Arias; Carolina Raventos; Jiabin Tang; Elena Guerini-Rocco; Elena Martínez-Sáez; Sergio Lois; Oscar Marín; Xavier de la Cruz; Salvatore Piscuoglio; Russel Towers; Ana Vivancos; Vicente Peg; Santiago Ramon y Cajal; Joan Carles; Jordi Rodon; María González-Cao; Josep Tabernero; Enriqueta Felip; Joan Sahuquillo; Michael F Berger; Javier Cortes; Jorge S Reis-Filho; Joan Seoane
Journal:  Nat Commun       Date:  2015-11-10       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.